newsfilter
← Latest News
GlobeNewswire·

Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)

  • Univest Securities, LLC acted as the sole placement agent for a registered direct offering of $12 million for China SXT Pharmaceuticals Inc. (NASDAQ: SXTC).
  • The Company sold 8,000,000 Class A ordinary shares (or pre-funded warrants) at $1.50 per share to institutional investors.
  • Investors received 8,000,000 warrants with an exercise price of $1.50 per share, a 1-year term, immediate exercisability, & a zero cash exercise option allowing acquisition of up to 9 shares per warrant.
  • The offering was conducted under a Form F-3 shelf registration statement declared effective by the SEC on December 1, 2025.
  • China SXT Pharmaceuticals Inc. is a Taizhou-based firm founded in 2005 that researches, develops, manufactures, markets, & sells processed traditional Chinese medicine pieces.